Zobrazeno 1 - 10
of 145
pro vyhledávání: '"François Vergez"'
Autor:
Camille Gondran, Pierre-Yves Dumas, Emilie Bérard, Audrey Bidet, Eric Delabesse, Suzanne Tavitian, Thibaut Leguay, Françoise Huguet, Cécile Borel, Edouard Forcade, François Vergez, Jean-Philippe Vial, Jean Baptiste Rieu, Nicolas Lechevalier, Isabelle Luquet, Alban Canali, Emilie Klein, Audrey Sarry, Anne-Charlotte de Grande, Arnaud Pigneux, Christian Récher, Laetitia Largeaud, Sarah Bertoli
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Acute myeloid leukemia (AML) with t(9;22) (q34.1; q11.2)/BCR::ABL1, a distinct entity within the group of AML with defining genetic abnormalities, belong to the adverse-risk group of the 2022 ELN classification. However, there is little data
Externí odkaz:
https://doaj.org/article/4053055ddfc042fab15037068bcb7414
Autor:
François Vergez, Laetitia Largeaud, Sarah Bertoli, Marie-Laure Nicolau, Jean-Baptiste Rieu, Inès Vergnolle, Estelle Saland, Audrey Sarry, Suzanne Tavitian, Françoise Huguet, Muriel Picard, Jean-Philippe Vial, Nicolas Lechevalier, Audrey Bidet, Pierre-Yves Dumas, Arnaud Pigneux, Isabelle Luquet, Véronique Mansat-De Mas, Eric Delabesse, Martin Carroll, Gwenn Danet-Desnoyers, Jean-Emmanuel Sarry, Christian Récher
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 8, Pp 1-11 (2022)
Abstract Classifications of acute myeloid leukemia (AML) patients rely on morphologic, cytogenetic, and molecular features. Here we have established a novel flow cytometry-based immunophenotypic stratification showing that AML blasts are blocked at s
Externí odkaz:
https://doaj.org/article/d9e29c225e7649168cd1370ebb1c8953
Publikováno v:
eJHaem, Vol 4, Iss 3, Pp 861-862 (2023)
Externí odkaz:
https://doaj.org/article/dc830c61061d4ab48a8205e53b23cf01
Autor:
Laetitia Largeaud, Sarah Bertoli, Emilie Bérard, Suzanne Tavitian, Muriel Picard, Stéphanie Dufrechou, Naïs Prade, François Vergez, Jean Baptiste Rieu, Isabelle Luquet, Audrey Sarry, Françoise Huguet, Jean Ruiz, Véronique De Mas, Eric Delabesse, Christian Récher
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-5 (2022)
Externí odkaz:
https://doaj.org/article/e6777d32c24343f19c5af917b8e953d9
Autor:
Jean Galtier, Camille Alric, Emilie Bérard, Thibaut Leguay, Suzanne Tavitian, Audrey Bidet, Eric Delabesse, Jean Baptiste Rieu, Jean-Philippe Vial, François Vergez, Nicolas Lechevalier, Isabelle Luquet, Emilie Klein, Anne-Charlotte de Grande, Audrey Sarry, Arnaud Pigneux, Christian Récher, Sarah Bertoli, Pierre-Yves Dumas
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 11, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/f96185a801b446e9a88718b9b046da3a
Autor:
Clément Larrue, Nathan Guiraud, Pierre-Luc Mouchel, Marine Dubois, Thomas Farge, Mathilde Gotanègre, Claudie Bosc, Estelle Saland, Marie-Laure Nicolau-Travers, Marie Sabatier, Nizar Serhan, Ambrine Sahal, Emeline Boet, Sarah Mouche, Quentin Heydt, Nesrine Aroua, Lucille Stuani, Tony Kaoma, Linus Angenendt, Jan-Henrik Mikesch, Christoph Schliemann, François Vergez, Jérôme Tamburini, Christian Récher, Jean-Emmanuel Sarry
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-15 (2021)
Leukemic stem cells which are resistant to chemotherapy are proposed as relapse-initiating cells (RICs). Here, the authors show that targeting the adrenomedullin-calcitonin receptor-like receptor decreases RICs frequency improving chemotherapy respon
Externí odkaz:
https://doaj.org/article/e5db0cc7b23d4c7f80b655c467b00921
Autor:
Alexej Knaus, François Vergez, Cédric Garcia, Hartmut Engels, Hela Hundertmark, David Ribes, Laetitia Largeaud, Suzanne Tavitian, Bernard Payrastre, Peter Krawitz, Stanislas Faguer, Agnes Ribes
Publikováno v:
Haematologica, Vol 107, Iss 8 (2022)
Externí odkaz:
https://doaj.org/article/50324bb3ed984f5ca9c44b6435f727aa
Autor:
Chloé Medrano, François Vergez, Catherine Mengelle, Stanislas Faguer, Nassim Kamar, Arnaud Del Bello
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 11, Pp 2145-2147 (2019)
Antibodies against PD1 have been used to treat progressive multifocal leukoencephalopathy (PML), a rare brain disease caused by JC virus. We used these antibodies (nivolumab) to treat PML in 3 kidney transplant recipients. All died within 8 weeks of
Externí odkaz:
https://doaj.org/article/22020d71fcca463d997c55b1998bb162
Autor:
Martin Gauthier, Françoise Durrieu, Elodie Martin, Michael Peres, François Vergez, Thomas Filleron, Lucie Obéric, Fontanet Bijou, Anne Quillet Mary, Loic Ysebaert
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Eradication of minimal residual disease (MRD), at the end of Fludarabine-Cyclophosphamide-Rituximab (FCR) treatment, is a validated surrogate marker for progression-free and overall survival in chronic lymphocytic leukaemia. But s
Externí odkaz:
https://doaj.org/article/ca51332e1168470592babd22abe18c80
Autor:
Alexis Piedrafita, François Vergez, Julie Belliere, Nais Prades, Magali Colombat, Antoine Huart, Jean-Baptiste Rieu, Stéphanie Lagarde, Arnaud Del Bello, Nassim Kamar, Dominique Chauveau, Camille Laurent, Lucie Oberic, Loïc Ysebaert, David Ribes, Stanislas Faguer
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 3, p 604 (2022)
Large granular T-cell leukemia is a clonal hematological condition often associated with autoimmune disorders. Whether small-sized T-cell clones that are otherwise asymptomatic can promote immune kidney disorders remains elusive. In this monocentric
Externí odkaz:
https://doaj.org/article/8818cbf78f84423587d37ac3457ed78f